About Utah Medical Products (NASDAQ:UTMD)
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company's product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Supplies
Trailing P/E Ratio41.6814047222914
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$41.41 million
Price / Sales8.53
Cash Flow$4.66 per share
Price / Cash20.37
Book Value$21.00 per share
Price / Book4.52
Net Income$8.50 million
Return on Equity18.85%
Return on Assets16.57%
Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions
What is Utah Medical Products' stock symbol?
Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."
How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?
Utah Medical Products declared a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, March 16th will be paid a dividend of $0.27 per share on Tuesday, April 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend is Thursday, March 15th. View Utah Medical Products' Dividend History.
How were Utah Medical Products' earnings last quarter?
Utah Medical Products, Inc. (NASDAQ:UTMD) released its earnings results on Tuesday, January, 30th. The medical instruments supplier reported $0.95 earnings per share (EPS) for the quarter. The medical instruments supplier earned $10.20 million during the quarter. Utah Medical Products had a return on equity of 18.85% and a net margin of 20.54%. View Utah Medical Products' Earnings History.
When will Utah Medical Products make its next earnings announcement?
Who are some of Utah Medical Products' key competitors?
Some companies that are related to Utah Medical Products include Invacare (IVC), STAAR Surgical (STAA), Meridian Bioscience (VIVO), AngioDynamics (ANGO), Lantheus (LNTH), PetIQ (PETQ), Tactile Systems Technology (TCMD), Mesa Laboratories (MLAB), Omeros (OMER), Viewray (VRAY), SurModics (SRDX), Insys Therapeutics (INSY), Accuray (ARAY), Quanterix (QTRX), Antares Pharma (ATRS), Endologix (ELGX), Oxford Immunotec Global (OXFD) and Pacific Biosciences of California (PACB).
Who are Utah Medical Products' key executives?
Utah Medical Products' management team includes the folowing people:
- Kevin L. Cornwell, Chairman of the Board, President, Chief Executive Officer and Secretary (Age 68)
- Paul O. Richins, Principal Financial Officer, Chief Administrative Officer, Vice President, Treasurer, Assistant Secretary, Director (Age 54)
- Ernst G. Hoyer, Lead Independent Director (Age 77)
- James H. Beeson M.D. Ph.D., Independent Director (Age 74)
- Barbara A. Payne Ph.D., Independent Director (Age 68)
Has Utah Medical Products been receiving favorable news coverage?
News articles about UTMD stock have been trending somewhat positive recently, Accern reports. Accern identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Utah Medical Products earned a coverage optimism score of 0.10 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 45.93 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Utah Medical Products' major shareholders?
Utah Medical Products' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (5.70%), BlackRock Inc. (4.35%), Geode Capital Management LLC (1.32%), Clean Yield Group (1.27%), Thomson Horstmann & Bryant Inc. (1.17%) and Wells Fargo & Company MN (0.77%). Company insiders that own Utah Medical Products stock include Ernst G Hoyer, Kevin L Cornwell and Paul O Richins. View Institutional Ownership Trends for Utah Medical Products.
Which institutional investors are selling Utah Medical Products stock?
UTMD stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Millennium Management LLC, Metropolitan Life Insurance Co. NY, Spark Investment Management LLC, Morgan Dempsey Capital Management LLC, Schwab Charles Investment Management Inc., Clean Yield Group and Rhumbline Advisers. Company insiders that have sold Utah Medical Products company stock in the last year include Ernst G Hoyer and Kevin L Cornwell. View Insider Buying and Selling for Utah Medical Products.
Which institutional investors are buying Utah Medical Products stock?
UTMD stock was purchased by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc., Renaissance Technologies LLC, Bailard Inc., Deutsche Bank AG, Allianz Asset Management GmbH, Geode Capital Management LLC, Cambridge Investment Research Advisors Inc. and BlackRock Inc.. View Insider Buying and Selling for Utah Medical Products.
How do I buy shares of Utah Medical Products?
Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Utah Medical Products' stock price today?
One share of UTMD stock can currently be purchased for approximately $94.95.
How big of a company is Utah Medical Products?
Utah Medical Products has a market capitalization of $353.08 million and generates $41.41 million in revenue each year. The medical instruments supplier earns $8.50 million in net income (profit) each year or $2.29 on an earnings per share basis. Utah Medical Products employs 183 workers across the globe.
How can I contact Utah Medical Products?
Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.
MarketBeat Community Rating for Utah Medical Products (UTMD)MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Utah Medical Products (NASDAQ:UTMD) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Utah Medical Products (NASDAQ:UTMD) Earnings History and Estimates Chart
Utah Medical Products (NASDAQ UTMD) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|1/30/2018||Q4 2017||$0.95||$10.20 million||View||N/A|
|10/24/2017||Q3 2017||$0.97||$10.13 million||View||N/A|
|7/25/2017||Q2 2017||$1.04||$10.83 million||View||N/A|
|4/25/2017||Q1 2017||$0.95||$10.26 million||View||N/A|
|1/31/2017||Q4 2016||$0.72||$8.85 million||View||N/A|
|11/4/2016||Q3 2016||$0.78||$9.66 million||View||N/A|
|2/2/2016||Q415||$0.85||$10.20 million||$9.58 million||View||N/A|
|10/22/2015||Q3 2015||$0.81||$9.95 million||View||N/A|
|4/23/2015||Q1 2015||$0.71||$10.23 million||View||N/A|
|1/29/2015||Q4 2014||$0.80||$10.24 million||View||N/A|
|7/24/2014||Q214||$0.69||$0.75||$10.00 million||$10.49 million||View||N/A|
|1/30/2014||Q413||$0.64||$0.91||$9.83 million||$10.09 million||View||N/A|
|7/25/2013||Q2 2013||$0.62||$0.70||$10.03 million||$10.00 million||View||N/A|
|4/25/2013||Q113||$0.73||$11.21 million||$10.37 million||View||N/A|
|1/31/2013||Q4 2012||$0.60||$9.90 million||$9.80 million||View||N/A|
Utah Medical Products (NASDAQ:UTMD) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Utah Medical Products (NASDAQ:UTMD) Dividend Information
|Payout Ratio:||47.16% (Trailing 12 Months of Earnings) |
Utah Medical Products (NASDAQ:UTMD) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Utah Medical Products (NASDAQ UTMD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 67.12%
Utah Medical Products (NASDAQ UTMD) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/12/2018||Kevin L Cornwell||CEO||Sell||1,100||$93.97||$103,367.00|| |
|3/8/2018||Kevin L Cornwell||CEO||Sell||7,034||$91.93||$646,635.62|| |
|2/22/2018||Kevin L Cornwell||CEO||Sell||1,095||$91.01||$99,655.95|| |
|2/15/2018||Ernst G Hoyer||Director||Sell||5,212||$89.11||$464,441.32||28,838|| |
|2/15/2018||Kevin L Cornwell||CEO||Sell||150||$91.13||$13,669.50|| |
|2/9/2018||Ernst G Hoyer||Director||Sell||1,529||$88.08||$134,674.32|| |
|2/2/2018||Ernst G Hoyer||Director||Sell||49||$91.00||$4,459.00|| |
|12/12/2016||Kevin L Cornwell||CEO||Sell||3,531||$69.25||$244,521.75|| |
|12/8/2016||Kevin L Cornwell||CEO||Sell||5,286||$70.10||$370,548.60|| |
|11/30/2016||Kevin L Cornwell||CEO||Sell||3,183||$69.03||$219,722.49|| |
|11/29/2016||Kevin L Cornwell||CEO||Sell||664||$69.00||$45,816.00|| |
|11/28/2016||Kevin L Cornwell||CEO||Sell||1,906||$69.05||$131,609.30|| |
|11/21/2016||Ernst G Hoyer||Director||Sell||362||$66.28||$23,993.36|| |
|11/17/2016||Ernst G Hoyer||Director||Sell||3,894||$66.30||$258,172.20|| |
|9/13/2016||Kevin L Cornwell||CEO||Sell||1,396||$63.09||$88,073.64|| |
|9/8/2016||Ernst G Hoyer||Director||Sell||63||$63.81||$4,020.03|| |
|9/7/2016||Kevin L Cornwell||CEO||Sell||408||$64.06||$26,136.48|| |
|8/31/2016||Kevin L Cornwell||CEO||Sell||716||$64.04||$45,852.64|| |
|8/29/2016||Kevin L Cornwell||CEO||Sell||2,200||$64.71||$142,362.00|| |
|8/15/2016||Kevin L Cornwell||CEO||Sell||23||$64.00||$1,472.00|| |
|8/10/2016||Kevin L Cornwell||CEO||Sell||1,800||$64.13||$115,434.00|| |
|5/31/2016||Paul O Richins||VP||Sell||396||$64.50||$25,542.00|| |
|5/27/2016||Paul O Richins||VP||Sell||271||$65.28||$17,690.88|| |
|11/10/2014||Kevin L Cornwell||CEO||Sell||3,472||$58.50||$203,112.00|| |
|3/14/2014||Ernst G Hoyer||Director||Sell||1,486||$56.04||$83,275.44|| |
|3/10/2014||Kevin L Cornwell||CEO||Sell||2,497||$55.45||$138,458.65|| |
|3/6/2014||Kevin L Cornwell||CEO||Sell||2,684||$55.69||$149,471.96|| |
|2/28/2014||Kevin L Cornwell||CEO||Sell||1,341||$55.48||$74,398.68|| |
|12/9/2013||Kevin L Cornwell||CEO||Sell||1,885||$51.65||$97,360.25|| |
|12/5/2013||Kevin L Cornwell||CEO||Sell||1,402||$51.55||$72,273.10|| |
|11/22/2013||Kevin L Cornwell||CEO||Sell||3,455||$53.13||$183,564.15|| |
|10/30/2013||Kevin L Cornwell||CEO||Sell||1,915||$56.40||$108,006.00|| |
|9/12/2013||Kevin L Cornwell||CEO||Sell||4,636||$50.50||$234,118.00|| |
|8/30/2013||Ernst G Hoyer||Director||Sell||10,000||$50.72||$507,200.00|| |
|8/23/2013||Kevin L Cornwell||CEO||Sell||5,715||$50.31||$287,521.65|| |
|7/31/2013||Kevin L Cornwell||CEO||Sell||8,100||$57.65||$466,965.00|| |
Utah Medical Products (NASDAQ UTMD) News Headlines
|Kevin L. Cornwell Sells 1,100 Shares of Utah Medical Products, Inc. (UTMD) Stock|
www.americanbankingnews.com - March 14 at 1:36 PM
|Utah Medical Products, Inc. (UTMD) CEO Kevin L. Cornwell Sells 7,034 Shares|
www.americanbankingnews.com - March 9 at 6:32 PM
|Utah Medical Products Inc (UTMD) Files 10-K for the Fiscal Year Ended on December 31, 2017|
finance.yahoo.com - March 6 at 5:05 PM
|Utah Medical Products, Inc. (UTMD) Holdings Lowered by Morgan Dempsey Capital Management LLC|
www.americanbankingnews.com - March 2 at 5:56 PM
|Utah Medical Products, Inc. (UTMD) CEO Sells $99,655.95 in Stock|
www.americanbankingnews.com - February 26 at 3:30 PM
|Utah Medical Products, Inc. (UTMD) CEO Kevin L. Cornwell Sells 150 Shares|
www.americanbankingnews.com - February 20 at 7:50 PM
|Utah Medical Products, Inc. (UTMD) Director Sells $464,441.32 in Stock|
www.americanbankingnews.com - February 15 at 9:26 PM
|Utah Medical Products, Inc. (UTMD) Declares Quarterly Dividend of $0.27|
www.americanbankingnews.com - February 14 at 10:46 AM
|Insider Selling: Utah Medical Products, Inc. (UTMD) Director Sells 1,529 Shares of Stock|
www.americanbankingnews.com - February 13 at 12:26 PM
|Utah Medical Products (UTMD) Rating Increased to Buy at BidaskClub|
www.americanbankingnews.com - February 7 at 6:02 AM
|BRIEF-Utah Medical Products Reports Qtrly GAAP Loss Per Share $0.674|
www.reuters.com - January 30 at 9:56 AM
|Utah Medical reports 4Q loss|
finance.yahoo.com - January 30 at 9:56 AM
|Utah Medical Products, Inc. Reports Audited Financial Performance for Fourth Quarter and Year 2017|
finance.yahoo.com - January 30 at 9:56 AM
|Should You Expect Utah Medical Products Inc (NASDAQ:UTMD) To Continue Delivering An ROE Of 17.86%?|
finance.yahoo.com - January 29 at 9:37 AM
|Utah Medical Products (UTMD) Scheduled to Post Earnings on Monday|
www.americanbankingnews.com - January 22 at 5:46 AM
|Critical Review: Utah Medical Products (UTMD) & Lombard Medical (EVARF)|
www.americanbankingnews.com - January 15 at 3:10 PM
|Utah Medical Products (UTMD) versus Asante Solutions (PUMP) Financial Comparison|
www.americanbankingnews.com - January 12 at 1:18 AM
|Reviewing Alliqua Biomedical (ALQA) and Utah Medical Products (UTMD)|
www.americanbankingnews.com - December 27 at 7:28 AM
|Contrasting Nevro (NVRO) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - December 25 at 9:42 AM
|ETFs with exposure to Utah Medical Products, Inc. : December 20, 2017|
finance.yahoo.com - December 20 at 5:40 PM
|Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : December 15th, 2017 (record date) : By the numbers : December 19, 2017|
finance.yahoo.com - December 19 at 5:43 PM
|Utah Medical Products (UTMD) Downgraded by BidaskClub|
www.americanbankingnews.com - December 13 at 12:22 AM
|Analyzing Utah Medical Products (UTMD) and LDR (LDRH)|
www.americanbankingnews.com - December 3 at 4:14 PM
|Head to Head Review: Utah Medical Products (UTMD) & ICU Medical (ICUI)|
www.americanbankingnews.com - November 28 at 11:40 AM
|Reviewing Utah Medical Products (UTMD) & Given Imaging (GIVN)|
www.americanbankingnews.com - November 26 at 1:30 PM
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017|
finance.yahoo.com - November 16 at 9:37 AM
|Comparing OraSure Technologies (OSUR) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - November 4 at 5:46 PM
|Utah Medical Products, Inc. (UTMD) Declares Dividend Increase - $0.27 Per Share|
www.americanbankingnews.com - November 1 at 10:32 AM
|Utah Medical Products (UTMD) Raises Quarterly Dividend 1.9% to $0.27; 1.4% Yield|
www.streetinsider.com - October 31 at 11:37 AM
|Lice Clinics of America Opens New Treatment Center in South Charlotte to Treat Super Lice|
globenewswire.com - October 25 at 2:07 AM
|Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2017|
feeds.benzinga.com - October 24 at 9:53 AM
|Is Utah Medical Products Inc (UTMD) A Buy At Its Current Price?|
finance.yahoo.com - October 23 at 8:48 AM
|Is Utah Medical Products Inc (UTMD) A Buy At Its Current Price?|
finance.yahoo.com - October 23 at 8:48 AM
|Utah Medical Products (UTMD) and Its Competitors Financial Survey|
www.americanbankingnews.com - October 21 at 12:14 PM
|Utah Medical Products (UTMD) and Its Competitors Critical Comparison|
www.americanbankingnews.com - October 18 at 6:36 AM
|Utah Medical Products, Inc. (UTMD) Scheduled to Post Earnings on Monday|
www.americanbankingnews.com - October 16 at 3:50 AM
|Reviewing Bio-Rad Laboratories (BIO) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - October 7 at 12:18 AM
|Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : September 15th, 2017 (record date) : By the numbers : October 4, 2017|
finance.yahoo.com - October 6 at 12:16 PM
|Cardiovascular Systems (CSII) and Utah Medical Products (UTMD) Head-To-Head Analysis|
www.americanbankingnews.com - October 1 at 12:18 PM
|Utah Medical Products (UTMD) and Its Rivals Head to Head Comparison|
www.americanbankingnews.com - September 26 at 12:32 PM
|Utah Medical Products goes ex-dividend tomorrow|
seekingalpha.com - September 13 at 10:50 AM
|Head-To-Head Comparison: Lombard Medical (EVAR) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - September 8 at 4:14 PM
|3 Top Small-Cap Blend Mutual Funds for Attractive Returns|
www.zacks.com - August 29 at 9:21 AM
|Utah Medical Products (UTMD) vs. Landauer (LDR) Financial Comparison|
www.americanbankingnews.com - August 27 at 10:24 PM
|Utah Medical Products (UTMD) vs. Antares Pharma (ATRS) Head-To-Head Survey|
www.americanbankingnews.com - August 15 at 2:20 AM
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017|
finance.yahoo.com - August 5 at 8:14 AM
|Utah Medical Products, Inc. Declares Quarterly Dividend of $0.27 (UTMD)|
www.americanbankingnews.com - August 4 at 2:22 PM
|Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017|
finance.yahoo.com - July 26 at 9:34 AM
|Utah Medical Products reports Q2 results|
seekingalpha.com - July 26 at 5:13 AM
|Utah Medical Products, Inc. (UTMD) Set to Announce Earnings on Monday|
www.americanbankingnews.com - July 22 at 10:23 AM
Utah Medical Products (NASDAQ:UTMD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Utah Medical Products (NASDAQ:UTMD) Income Statement, Balance Sheet and Cash Flow Statement
Utah Medical Products (NASDAQ UTMD) Stock Chart for Wednesday, March, 21, 2018